Non-Hodgkin's lymphoma

Clinical trials for Non-Hodgkin's lymphoma explained in plain language.

Never miss a new study

Get alerted when new Non-Hodgkin's lymphoma trials appear

Sign up with your email to follow new studies for Non-Hodgkin's lymphoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 18 Not yet recruiting 1 Not yet finished but already full! 15 Completed 5 Terminated 1

Drug combo aims to control Slow-Growing lymphoma without chemo

Disease control Stopped early

This phase 2 study tested a combination of two drugs, lenalidomide and rituximab, in 30 people with previously untreated indolent non-Hodgkin's lymphoma. The goal was to see how well the drugs worked together to shrink or control the cancer. Participants took lenalidomide daily f…

Matched conditions: NON-HODGKIN'S LYMPHOMA

Phase 2 • Sponsor: University of California, Davis • Aim: Disease control

Last updated Jun 27, 2026 07:59 UTC

Non-Hodgkin's lymphoma

Get alerted when new Non-Hodgkin's lymphoma trials appear

Drug combo aims to control Slow-Growing lymphoma without chemo